Tivity Health’s (NASDAQ:TVTY) “Sell” Rating Reaffirmed at Zacks Investment Research

Tivity Health (NASDAQ:TVTY)‘s stock had its “sell” rating restated by Zacks Investment Research in a report issued on Saturday, January 6th.

According to Zacks, “Tivity Health, Inc. provides health management services. The company offers services which include chiropractic services, physical therapy, occupational therapy, speech therapy, acupuncture, massage and complementary and alternative medicine services. Its network comprises SilverSneakers(R), Prime(R) Fitness and WholeHealth Living (TM). Tivity Health, Inc., formerly known as Healthways, Inc., is based in Franklin, Tennessee. “

Several other equities research analysts have also issued reports on the company. BidaskClub lowered Tivity Health from a “buy” rating to a “hold” rating in a report on Thursday, January 4th. Barrington Research reissued an “outperform” rating and issued a $40.00 price objective (down from $46.00) on shares of Tivity Health in a research note on Tuesday, November 7th. ValuEngine downgraded Tivity Health from a “buy” rating to a “hold” rating in a research note on Monday, November 6th. Cantor Fitzgerald reissued a “buy” rating and issued a $45.00 price objective on shares of Tivity Health in a research note on Monday, November 6th. Finally, Oppenheimer raised their price objective on Tivity Health from $47.00 to $50.00 and gave the company an “outperform” rating in a research note on Wednesday, November 1st. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Tivity Health currently has a consensus rating of “Buy” and an average target price of $45.25.

Shares of Tivity Health (NASDAQ TVTY) traded down $0.20 during midday trading on Friday, reaching $38.60. The company’s stock had a trading volume of 57,689 shares, compared to its average volume of 382,387. The firm has a market cap of $1,556.94, a price-to-earnings ratio of 23.96, a PEG ratio of 2.03 and a beta of 0.18. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.60 and a quick ratio of 0.60. Tivity Health has a 12-month low of $24.05 and a 12-month high of $48.50.

In other news, Director Conan Laughlin sold 490,000 shares of the business’s stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $34.34, for a total transaction of $16,826,600.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Mary Flipse sold 5,000 shares of the business’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $48.11, for a total value of $240,550.00. Following the completion of the sale, the insider now directly owns 45,167 shares in the company, valued at approximately $2,172,984.37. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 875,892 shares of company stock worth $31,815,642. 8.42% of the stock is currently owned by company insiders.

Hedge funds have recently made changes to their positions in the stock. Nationwide Fund Advisors boosted its stake in Tivity Health by 20.4% in the 3rd quarter. Nationwide Fund Advisors now owns 238,768 shares of the company’s stock valued at $9,742,000 after buying an additional 40,492 shares in the last quarter. Chartwell Investment Partners LLC boosted its stake in Tivity Health by 194.6% in the third quarter. Chartwell Investment Partners LLC now owns 111,754 shares of the company’s stock worth $4,559,000 after purchasing an additional 73,819 shares in the last quarter. Neuberger Berman Group LLC boosted its stake in Tivity Health by 587.7% in the third quarter. Neuberger Berman Group LLC now owns 1,633,016 shares of the company’s stock worth $66,627,000 after purchasing an additional 1,395,539 shares in the last quarter. Crossmark Global Holdings Inc. acquired a new position in Tivity Health in the third quarter worth $279,000. Finally, Eaton Vance Management acquired a new position in Tivity Health in the second quarter worth $625,000.

ILLEGAL ACTIVITY NOTICE: This piece was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/31/tivity-health-tvty-given-sell-rating-at-zacks-investment-research.html.

About Tivity Health

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Get a free copy of the Zacks research report on Tivity Health (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply